[
  {
    "ts": null,
    "headline": "Bio-Techne Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Bio-Techne Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=c04adf66ab982653094d00b56f5a9ae2bbd8a5800603361583a99b9fd7c119bb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750785600,
      "headline": "Bio-Techne Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 135613795,
      "image": "",
      "related": "TECH",
      "source": "MarketWatch",
      "summary": "Bio-Techne Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=c04adf66ab982653094d00b56f5a9ae2bbd8a5800603361583a99b9fd7c119bb"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards with its analytical solutions, including the Maurice system, to support monoclonal antibody and gene therapy development around the world.",
    "url": "https://finnhub.io/api/news?id=0b692c837c80742cd5f9745280638ccb8e8731845c93377364cbb7dbb4b22fed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750762800,
      "headline": "Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development",
      "id": 135507067,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards with its analytical solutions, including the Maurice system, to support monoclonal antibody and gene therapy development around the world.",
      "url": "https://finnhub.io/api/news?id=0b692c837c80742cd5f9745280638ccb8e8731845c93377364cbb7dbb4b22fed"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne Corporation and U.S. Pharmacopeia Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development",
    "summary": "Bio-Techne Corporation announced a distribution agreement with the U.S. Pharmacopeia that enables the Company to sell USP monoclonal antibody and recombant adeno-associated virus reference...",
    "url": "https://finnhub.io/api/news?id=0385b1984d36bd91ceab0032b0938867e9526285d2ac7f317bfb0880f355fd45",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750754154,
      "headline": "Bio-Techne Corporation and U.S. Pharmacopeia Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development",
      "id": 135497052,
      "image": "",
      "related": "TECH",
      "source": "Finnhub",
      "summary": "Bio-Techne Corporation announced a distribution agreement with the U.S. Pharmacopeia that enables the Company to sell USP monoclonal antibody and recombant adeno-associated virus reference...",
      "url": "https://finnhub.io/api/news?id=0385b1984d36bd91ceab0032b0938867e9526285d2ac7f317bfb0880f355fd45"
    }
  }
]